CN Stock MarketDetailed Quotes

688117 Cheng Du Sheng Nuo Biotec

Watchlist
  • 22.75
  • +0.05+0.22%
Market Closed Aug 2 15:00 CST
2.55BMarket Cap35.38P/E (TTM)

Cheng Du Sheng Nuo Biotec Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
14.44%198.94M
27.65%104.06M
9.93%435.02M
11.82%291.23M
3.78%173.83M
0.96%81.52M
2.38%395.72M
-6.70%260.43M
-13.49%167.51M
-13.44%80.74M
Operating revenue
14.44%198.94M
27.65%104.06M
9.93%435.02M
11.82%291.23M
3.78%173.83M
0.96%81.52M
2.38%395.72M
-6.70%260.43M
-13.49%167.51M
-13.44%80.74M
Total operating cost
11.99%176.47M
19.14%86.93M
11.01%357.48M
17.38%254.71M
5.89%157.57M
10.64%72.96M
1.61%322.02M
-5.88%216.99M
-10.23%148.81M
-17.56%65.95M
Operating cost
31.65%80.4M
32.20%38.37M
15.37%157.65M
14.95%107.76M
2.29%61.07M
10.01%29.03M
26.13%136.64M
33.17%93.75M
26.27%59.71M
37.17%26.38M
Operating tax surcharges
41.14%2.58M
122.81%1.32M
-14.54%4.03M
-22.69%2.61M
-26.67%1.83M
-53.10%594.35K
-1.71%4.72M
1.68%3.37M
7.56%2.49M
17.77%1.27M
Operating expense
-26.85%35.68M
19.93%23.18M
-4.65%107.97M
6.91%79.66M
-4.27%48.77M
-20.92%19.33M
-25.37%113.24M
-39.40%74.52M
-43.38%50.95M
-47.57%24.44M
Administration expense
-0.75%30.48M
-25.85%12.62M
17.92%53.86M
39.73%40.78M
45.14%30.71M
86.15%17.02M
13.75%45.68M
7.65%29.19M
10.10%21.16M
5.50%9.14M
Financial expense
74.16%3.49M
-5.30%2.02M
417.50%4.91M
232.06%3.52M
232.99%2.01M
639.17%2.14M
16.31%-1.55M
-23.85%-2.66M
-434.76%-1.51M
34.44%-396.26K
-Interest expense (Financial expense)
21.24%5.27M
47.75%2.94M
164.68%9.26M
199.24%6.83M
303.35%4.34M
339.82%1.99M
1,949.84%3.5M
8,811.52%2.28M
--1.08M
--451.87K
-Interest Income (Financial expense)
38.82%-1.23M
-14.86%-838.48K
-86.50%-3.92M
-96.23%-2.73M
-78.71%-2.01M
-20.48%-729.97K
23.19%-2.1M
46.39%-1.39M
-70.84%-1.13M
-57.50%-605.88K
Research and development
80.85%23.83M
93.65%9.42M
24.74%29.05M
8.23%20.38M
-17.69%13.18M
-4.87%4.86M
69.40%23.29M
111.11%18.83M
120.57%16.01M
2.00%5.11M
Credit Impairment Loss
397.80%1.95M
408.03%1.43M
12.71%-3.05M
-3.57%-593.15K
-200.53%-656.3K
-208.26%-464.7K
-171.12%-3.49M
-275.10%-572.68K
13.44%-218.38K
-31.21%429.23K
Asset Impairment Loss
-88.99%-4.75M
-289.31%-874.48K
-2.68%-4.93M
-361.49%-4.26M
-4,699.08%-2.51M
-3,393.77%-224.62K
-280.75%-4.8M
-221.60%-924.17K
90.59%-52.39K
98.33%-6.43K
Other net revenue
Invest income
272.73%697.98K
153.81%298.89K
-157.63%-1.42M
-163.84%-900.47K
-146.82%-404.08K
-150.70%-555.46K
68.33%2.47M
--1.41M
--863.08K
--1.1M
-Including: Investment income associates
----
----
-66.18%-3.17M
----
----
----
---1.91M
----
----
----
Asset deal income
103.30%35
103.30%35
98.66%-1.06K
90.48%-1.06K
90.48%-1.06K
90.48%-1.06K
-487.73%-79.37K
---11.15K
---11.15K
---11.15K
Other revenue
-68.01%3.44M
-82.22%1.61M
156.62%12.96M
255.64%11.18M
334.04%10.74M
579.05%9.04M
-30.84%5.05M
-31.97%3.14M
-32.59%2.47M
111.26%1.33M
Operating profit
1.61%23.81M
19.82%19.59M
11.34%81.1M
-9.79%41.94M
7.69%23.43M
-7.31%16.35M
-3.92%72.84M
-12.68%46.49M
-29.20%21.76M
24.60%17.64M
Add:Non operating Income
-89.47%26.11K
265,909.48%21.33K
9,770.38%333.48K
3,473.84%318.49K
2,926.72%247.89K
-99.90%8.02
-83.59%3.38K
-92.56%8.91K
-93.14%8.19K
-88.51%7.95K
Less:Non operating expense
-40.29%533.42K
1,780.04%307.63K
173.22%1.31M
207.97%1.19M
151.89%893.34K
-80.75%16.36K
-91.01%480.58K
-86.35%386.33K
-85.13%354.66K
-90.60%85K
Total profit
2.26%23.3M
18.19%19.3M
10.72%80.12M
-10.94%41.06M
6.42%22.78M
-7.00%16.33M
2.66%72.36M
-8.74%46.11M
-24.78%21.41M
31.84%17.56M
Less:Income tax cost
-40.00%1.58M
24.08%2.85M
24.34%9.8M
-11.77%6.27M
-4.79%2.64M
-29.65%2.3M
-14.68%7.88M
-5.18%7.1M
-37.84%2.77M
96.18%3.27M
Net profit
7.79%21.72M
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
Net profit from continuing operation
7.79%21.72M
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
Less:Minority Profit
---69.31K
---22.09K
---12.7K
----
----
----
----
----
----
----
Net profit of parent company owners
8.14%21.79M
17.38%16.47M
9.08%70.34M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
Earning per share
Basic earning per share
5.56%0.19
15.38%0.15
8.62%0.63
-11.43%0.31
5.88%0.18
-27.78%0.13
-31.76%0.58
-43.55%0.35
-55.26%0.17
-5.26%0.18
Diluted earning per share
5.56%0.19
15.38%0.15
6.90%0.62
-11.43%0.31
5.88%0.18
-27.78%0.13
-31.76%0.58
-43.55%0.35
-55.26%0.17
-5.26%0.18
Other composite income
Total composite income
7.79%21.72M
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
Total composite income of parent company owners
8.14%21.79M
17.38%16.47M
9.08%70.34M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
Total composite income of minority owners
---69.31K
---22.09K
---12.7K
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 14.44%198.94M27.65%104.06M9.93%435.02M11.82%291.23M3.78%173.83M0.96%81.52M2.38%395.72M-6.70%260.43M-13.49%167.51M-13.44%80.74M
Operating revenue 14.44%198.94M27.65%104.06M9.93%435.02M11.82%291.23M3.78%173.83M0.96%81.52M2.38%395.72M-6.70%260.43M-13.49%167.51M-13.44%80.74M
Total operating cost 11.99%176.47M19.14%86.93M11.01%357.48M17.38%254.71M5.89%157.57M10.64%72.96M1.61%322.02M-5.88%216.99M-10.23%148.81M-17.56%65.95M
Operating cost 31.65%80.4M32.20%38.37M15.37%157.65M14.95%107.76M2.29%61.07M10.01%29.03M26.13%136.64M33.17%93.75M26.27%59.71M37.17%26.38M
Operating tax surcharges 41.14%2.58M122.81%1.32M-14.54%4.03M-22.69%2.61M-26.67%1.83M-53.10%594.35K-1.71%4.72M1.68%3.37M7.56%2.49M17.77%1.27M
Operating expense -26.85%35.68M19.93%23.18M-4.65%107.97M6.91%79.66M-4.27%48.77M-20.92%19.33M-25.37%113.24M-39.40%74.52M-43.38%50.95M-47.57%24.44M
Administration expense -0.75%30.48M-25.85%12.62M17.92%53.86M39.73%40.78M45.14%30.71M86.15%17.02M13.75%45.68M7.65%29.19M10.10%21.16M5.50%9.14M
Financial expense 74.16%3.49M-5.30%2.02M417.50%4.91M232.06%3.52M232.99%2.01M639.17%2.14M16.31%-1.55M-23.85%-2.66M-434.76%-1.51M34.44%-396.26K
-Interest expense (Financial expense) 21.24%5.27M47.75%2.94M164.68%9.26M199.24%6.83M303.35%4.34M339.82%1.99M1,949.84%3.5M8,811.52%2.28M--1.08M--451.87K
-Interest Income (Financial expense) 38.82%-1.23M-14.86%-838.48K-86.50%-3.92M-96.23%-2.73M-78.71%-2.01M-20.48%-729.97K23.19%-2.1M46.39%-1.39M-70.84%-1.13M-57.50%-605.88K
Research and development 80.85%23.83M93.65%9.42M24.74%29.05M8.23%20.38M-17.69%13.18M-4.87%4.86M69.40%23.29M111.11%18.83M120.57%16.01M2.00%5.11M
Credit Impairment Loss 397.80%1.95M408.03%1.43M12.71%-3.05M-3.57%-593.15K-200.53%-656.3K-208.26%-464.7K-171.12%-3.49M-275.10%-572.68K13.44%-218.38K-31.21%429.23K
Asset Impairment Loss -88.99%-4.75M-289.31%-874.48K-2.68%-4.93M-361.49%-4.26M-4,699.08%-2.51M-3,393.77%-224.62K-280.75%-4.8M-221.60%-924.17K90.59%-52.39K98.33%-6.43K
Other net revenue
Invest income 272.73%697.98K153.81%298.89K-157.63%-1.42M-163.84%-900.47K-146.82%-404.08K-150.70%-555.46K68.33%2.47M--1.41M--863.08K--1.1M
-Including: Investment income associates ---------66.18%-3.17M---------------1.91M------------
Asset deal income 103.30%35103.30%3598.66%-1.06K90.48%-1.06K90.48%-1.06K90.48%-1.06K-487.73%-79.37K---11.15K---11.15K---11.15K
Other revenue -68.01%3.44M-82.22%1.61M156.62%12.96M255.64%11.18M334.04%10.74M579.05%9.04M-30.84%5.05M-31.97%3.14M-32.59%2.47M111.26%1.33M
Operating profit 1.61%23.81M19.82%19.59M11.34%81.1M-9.79%41.94M7.69%23.43M-7.31%16.35M-3.92%72.84M-12.68%46.49M-29.20%21.76M24.60%17.64M
Add:Non operating Income -89.47%26.11K265,909.48%21.33K9,770.38%333.48K3,473.84%318.49K2,926.72%247.89K-99.90%8.02-83.59%3.38K-92.56%8.91K-93.14%8.19K-88.51%7.95K
Less:Non operating expense -40.29%533.42K1,780.04%307.63K173.22%1.31M207.97%1.19M151.89%893.34K-80.75%16.36K-91.01%480.58K-86.35%386.33K-85.13%354.66K-90.60%85K
Total profit 2.26%23.3M18.19%19.3M10.72%80.12M-10.94%41.06M6.42%22.78M-7.00%16.33M2.66%72.36M-8.74%46.11M-24.78%21.41M31.84%17.56M
Less:Income tax cost -40.00%1.58M24.08%2.85M24.34%9.8M-11.77%6.27M-4.79%2.64M-29.65%2.3M-14.68%7.88M-5.18%7.1M-37.84%2.77M96.18%3.27M
Net profit 7.79%21.72M17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M
Net profit from continuing operation 7.79%21.72M17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M
Less:Minority Profit ---69.31K---22.09K---12.7K----------------------------
Net profit of parent company owners 8.14%21.79M17.38%16.47M9.08%70.34M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M
Earning per share
Basic earning per share 5.56%0.1915.38%0.158.62%0.63-11.43%0.315.88%0.18-27.78%0.13-31.76%0.58-43.55%0.35-55.26%0.17-5.26%0.18
Diluted earning per share 5.56%0.1915.38%0.156.90%0.62-11.43%0.315.88%0.18-27.78%0.13-31.76%0.58-43.55%0.35-55.26%0.17-5.26%0.18
Other composite income
Total composite income 7.79%21.72M17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M
Total composite income of parent company owners 8.14%21.79M17.38%16.47M9.08%70.34M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M
Total composite income of minority owners ---69.31K---22.09K---12.7K----------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg